Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (11-20 of 741) with videos related to

Pageof 75
Sort By:
JAMA|November 4, 2010
Are CSF biomarkers ready for prime time as diagnostics for Alzheimer disease? Interview by Rebecca VoelkerDavid M Holtzman
Archives of Neurology|March 14, 2007
Pittsburgh compound B retention and verification of amyloid depositionDavid M Holtzman
Gerodontics|December 1, 1988
Promoting appropriate responses to oral health symptoms in the agedJ M Holtzman
Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry|February 9, 2002
Just another pretty face? Facial attractiveness and oral appearance in old ageJ M Holtzman
Archives of Neurology|April 25, 2012
CSF biomarkers for secondary prevention trials: why markers of amyloid deposition and neurodegeneration are both importantDavid M Holtzman
Archives of Neurology|December 17, 2009
Cerebrospinal fluid beta-amyloid 42, Tau, and P-tau: confirmation now realizationDavid M Holtzman
Journal of Molecular Neuroscience : MN|June 8, 2004
In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathologyDavid M Holtzman
Harefuah|June 1, 1982
[Hereditary mirror movements]S Harel, M Holtzman
Harefuah|January 2, 1983
[Cerebellar agenesis]M Holtzman, S Harel
The Gerontologist|February 1, 1985
What children see: the aged on television in Japan and the United StatesJ M Holtzman, H Akiyama
Pageof 75

Showing results (11-20 of 741) with videos related to

Sort By:
Pageof 75
JAMA|November 4, 2010
Are CSF biomarkers ready for prime time as diagnostics for Alzheimer disease? Interview by Rebecca VoelkerDavid M Holtzman
Archives of Neurology|March 14, 2007
Pittsburgh compound B retention and verification of amyloid depositionDavid M Holtzman
Gerodontics|December 1, 1988
Promoting appropriate responses to oral health symptoms in the agedJ M Holtzman
Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry|February 9, 2002
Just another pretty face? Facial attractiveness and oral appearance in old ageJ M Holtzman
Archives of Neurology|April 25, 2012
CSF biomarkers for secondary prevention trials: why markers of amyloid deposition and neurodegeneration are both importantDavid M Holtzman
Archives of Neurology|December 17, 2009
Cerebrospinal fluid beta-amyloid 42, Tau, and P-tau: confirmation now realizationDavid M Holtzman
Journal of Molecular Neuroscience : MN|June 8, 2004
In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathologyDavid M Holtzman
Harefuah|June 1, 1982
[Hereditary mirror movements]S Harel, M Holtzman
Harefuah|January 2, 1983
[Cerebellar agenesis]M Holtzman, S Harel
The Gerontologist|February 1, 1985
What children see: the aged on television in Japan and the United StatesJ M Holtzman, H Akiyama
Pageof 75